The cross-sectional study by Arya et al. [185] aimed at comparing oxidative stress markers and antioxidant enzyme activity in 60 patients with MASLD versus 25 healthy individuals, finding significantly higher levels of alanine aminotransferase, MDA, and nitric oxide metabolites in MASLD patients, along with lower total thiol levels and SOD activity compared to the controls. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.